STEADYMED THERAPEUTICS, INC. LOAN AND SECURITY AGREEMENTLoan and Security Agreement • September 17th, 2014 • SteadyMed Ltd. • Pharmaceutical preparations • California
This LOAN AND SECURITY AGREEMENT (the “Agreement”) is entered into as of February 20, 2013, by and between Square 1 Bank (“Bank”) and SteadyMed Therapeutics, Inc. (“Borrower”).
ORIGINAL BISHOP RANCH BUILDING LEASE A Sunset Development Project One Annabel Lane, Suite 201 | San Ramon, CA 94583 tel 925.866.0100 fax 925.866.1330 www.bishopranch.comLease • September 17th, 2014 • SteadyMed Ltd. • Pharmaceutical preparations • California
THIS LEASE made as of this 20th day of September, 2012, between LANDLORD, whose full name and address is set forth below, and TENANT, whose full name and address is set forth below.
FIRST LEASE ADDENDUMFirst Lease Addendum • September 17th, 2014 • SteadyMed Ltd. • Pharmaceutical preparations
THIS. FIRST LEASE ADDENDUM IS MADE AND ENTERED INTO THIS 11th DAY OF JUNE, 2013, BY AND BETWEEN ANNABEL INVESTMENT COMPANY, A CALIFORNIA LIMITED PARTNERSHIP (HEREINAFTER REFERRED TO AS “LANDLORD”) AND STEADYMED THERAPEUTICS, INC. (HEREINAFTER REFERRED TO AS “TENANT”).
STEADYMED LTD. FOURTH AMENDED INVESTORS RIGHTS AGREEMENTInvestors Rights Agreement • September 17th, 2014 • SteadyMed Ltd. • Pharmaceutical preparations
This Fourth Amended Investors Rights Agreement (the “Agreement”) is made as of February 24th, 2014, by and among (i) SteadyMed Ltd., an Israeli company (the “Company”), (ii) the persons and entities identified in Schedule 1 hereto (individually or collectively) referred to herein as “Preferred E Holder(s)” (iii) the persons and entities identified in Schedule 1 hereto (individually or collectively ) referred to herein as “Preferred D Holder(s)” (iv) the persons and entities identified in Schedule 1 hereto (individually or collectively referred to herein as “Preferred C Holder(s)” (v) the persons and entities identified in Schedule 1 hereto (individually or collectively referred to herein as the “Preferred B Holder(s)”, (the Preferred E Holders, the Preferred D Holders, the Preferred C Holders and the Preferred B Holders shall be also referred to herein collectively as “Investor(s)” as the context requires) (vi) the holders of Series A2 Preferred Shares of the Company identified in Sche
